Commit To Purchase Alnylam Pharmaceuticals At $35, Earn 20.9% Annualized Using Options
February 23, 2017 at 11:54 AM EST
Investors considering a purchase of Alnylam Pharmaceuticals Inc (ALNY) stock, but cautious about paying the going market price of $45.91/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the October put at the $35 strike, which has a bid at the time of this writing of $4.80..